Can We Predict Renal Function Recovery After Pyeloplasty in Pediatrics with Ureteropelvic Junction Obstruction? A

Safendra Siregar1, Akhmad Mustafa1, Steven Steven1

  • 1Department of Urology, Hasan Sadikin Academic Medical Center, Universitas Padjadjaran, Bandung, Indonesia.

PubMed

Insights

Predicting renal function recovery after pyeloplasty for ureteropelvic junction obstruction is crucial. Preoperative differential renal function (DRF) is a key predictor, guiding treatment for chronic unilateral renal obstruction.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Outcomes Research

Background:

  • Chronic unilateral renal obstruction, often due to ureteropelvic junction obstruction (UPJO), necessitates timely surgical intervention to preserve kidney function.
  • Current diagnostic methods lack definitive predictors for surgical outcomes, creating challenges in treatment planning.

Purpose of the Study:

  • To systematically review and identify predictors of renal function recovery following pyeloplasty in patients with UPJO.
  • To inform clinical decision-making and optimize treatment strategies for chronic unilateral renal obstruction.

Main Methods:

  • A systematic review adhering to PRISMA guidelines was conducted.
  • Literature search across PubMed, Embase, and Scopus (up to March 10, 2022) for studies on renal function, pyeloplasty, and predictors.
  • Quality assessment using the Newcastle-Ottawa Scale; 11 studies (925 participants) were included.

Main Results:

  • Age and gender were not significant predictors of functional recovery post-pyeloplasty.
  • Preoperative differential renal function (DRF) consistently emerged as a critical predictor of renal function recovery.
  • The quality of included studies was generally average, with most assessing renal function via DRF.

Conclusions:

  • Preoperative DRF is a valuable predictor for renal function recovery after pyeloplasty in UPJO.
  • Findings aid in understanding treatment options for chronic unilateral renal obstruction.
  • Further research is required to validate identified predictors and their clinical utility.